home / stock / mreo / mreo quote
Last: | $3.01 |
---|---|
Change Percent: | 0.32% |
Open: | $3.09 |
Close: | $3.01 |
High: | $3.13 |
Low: | $2.97 |
Volume: | 687,544 |
Last Trade Date Time: | 05/07/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$3.01 | $3.09 | $3.01 | $3.13 | $2.97 | 687,544 | 05-07-2024 |
$3.1 | $3.3 | $3.1 | $3.31 | $3.01 | 834,894 | 05-06-2024 |
$3.26 | $3.16 | $3.26 | $3.35 | $3.14 | 855,585 | 05-03-2024 |
$3.11 | $3.18 | $3.11 | $3.24 | $3.11 | 431,767 | 05-02-2024 |
$3.15 | $3.06 | $3.15 | $3.22 | $3.01 | 1,962,063 | 05-01-2024 |
$3.05 | $2.75 | $3.05 | $3.09 | $2.71 | 1,579,127 | 04-30-2024 |
$2.76 | $2.75 | $2.76 | $2.815 | $2.6701 | 530,508 | 04-29-2024 |
$2.74 | $2.81 | $2.74 | $2.81 | $2.73 | 562,550 | 04-26-2024 |
$2.81 | $2.75 | $2.81 | $2.82 | $2.64 | 1,031,323 | 04-25-2024 |
$2.78 | $2.76 | $2.78 | $2.885 | $2.76 | 572,866 | 04-24-2024 |
$2.78 | $2.81 | $2.78 | $2.851 | $2.75 | 790,447 | 04-23-2024 |
$2.79 | $2.73 | $2.79 | $2.81 | $2.6201 | 1,064,979 | 04-22-2024 |
$2.64 | $2.62 | $2.64 | $2.668 | $2.53 | 912,723 | 04-19-2024 |
$2.65 | $2.56 | $2.65 | $2.675 | $2.525 | 814,717 | 04-18-2024 |
$2.58 | $2.7 | $2.58 | $2.71 | $2.58 | 601,205 | 04-17-2024 |
$2.69 | $2.68 | $2.69 | $2.7 | $2.61 | 591,800 | 04-16-2024 |
$2.67 | $2.68 | $2.67 | $2.7199 | $2.605 | 1,251,329 | 04-15-2024 |
$2.72 | $2.8 | $2.72 | $2.8199 | $2.64 | 1,311,047 | 04-12-2024 |
$2.74 | $2.96 | $2.74 | $2.997 | $2.72 | 1,651,245 | 04-11-2024 |
$2.94 | $3.03 | $2.94 | $3.07 | $2.93 | 776,215 | 04-10-2024 |
News, Short Squeeze, Breakout and More Instantly...
Mereo BioPharma Group Company Name:
MREO Stock Symbol:
NASDAQ Market:
LONDON, April 03, 2024 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ:MREO) ("Mereo" or the "Company"), a clinical-stage biopharmaceutica...
LONDON, April 03, 2024 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo” or the “Company”), a clinical-stage biopharmaceutical company focused on rare diseases, today announced that Dr. Denise Scots-Knight, Chief Executive Officer, will participate ...
2024-03-28 08:00:08 ET Gil Blum from Needham issued a price target of $6.00 for MREO on 2024-03-28 07:08:00. The adjusted price target was set to $6.00. At the time of the announcement, MREO was trading at $3. The overall price target consensus is at $4.00 with high pric...